Intra Cellular Stock Forecast - Naive Prediction
| ITCIDelisted Stock | USD 131.87 0.03 0.02% |
The Naive Prediction forecasted value of Intra Cellular Therapies on the next trading day is expected to be 134.87 with a mean absolute deviation of 2.17 and the sum of the absolute errors of 132.38. Intra Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Intra Cellular's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 24th of January 2026 the value of rsi of Intra Cellular's share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Intra Cellular hype-based prediction, you can estimate the value of Intra Cellular Therapies from the perspective of Intra Cellular response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Intra Cellular Therapies on the next trading day is expected to be 134.87 with a mean absolute deviation of 2.17 and the sum of the absolute errors of 132.38. Intra Cellular after-hype prediction price | USD 131.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Intra |
Intra Cellular Additional Predictive Modules
Most predictive techniques to examine Intra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intra using various technical indicators. When you analyze Intra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Intra Cellular Naive Prediction Price Forecast For the 25th of January
Given 90 days horizon, the Naive Prediction forecasted value of Intra Cellular Therapies on the next trading day is expected to be 134.87 with a mean absolute deviation of 2.17, mean absolute percentage error of 18.18, and the sum of the absolute errors of 132.38.Please note that although there have been many attempts to predict Intra Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Intra Cellular's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Intra Cellular Stock Forecast Pattern
| Backtest Intra Cellular | Intra Cellular Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Intra Cellular stock data series using in forecasting. Note that when a statistical model is used to represent Intra Cellular stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.0107 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.1701 |
| MAPE | Mean absolute percentage error | 0.0202 |
| SAE | Sum of the absolute errors | 132.3766 |
Predictive Modules for Intra Cellular
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intra Cellular Therapies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intra Cellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intra Cellular After-Hype Price Prediction Density Analysis
As far as predicting the price of Intra Cellular at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intra Cellular or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Intra Cellular, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Intra Cellular Estimiated After-Hype Price Volatility
In the context of predicting Intra Cellular's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intra Cellular's historical news coverage. Intra Cellular's after-hype downside and upside margins for the prediction period are 131.87 and 131.87, respectively. We have considered Intra Cellular's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Intra Cellular is very steady at this time. Analysis and calculation of next after-hype price of Intra Cellular Therapies is based on 3 months time horizon.
Intra Cellular Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Intra Cellular is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intra Cellular backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intra Cellular, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
131.87 | 131.87 | 0.00 |
|
Intra Cellular Hype Timeline
Intra Cellular Therapies is currently traded for 131.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Intra is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Intra Cellular is about 0.0%, with the expected price after the next announcement by competition of 131.87. About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.73. Intra Cellular Therapies had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.Intra Cellular Related Hype Analysis
Having access to credible news sources related to Intra Cellular's direct competition is more important than ever and may enhance your ability to predict Intra Cellular's future price movements. Getting to know how Intra Cellular's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intra Cellular may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CTLT | Catalent | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BDX | Becton Dickinson and | 3.89 | 10 per month | 0.83 | 0.05 | 2.93 | (1.52) | 6.92 | |
| RVTY | Revvity | (2.83) | 29 per month | 1.45 | 0.12 | 4.52 | (2.84) | 8.40 | |
| KRTX | Karuna Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SWAV | Shockwave Medical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ABMD | ABIOMED | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WBA | Walgreens Boots Alliance | 1.87 | 3 per month | 0.07 | 0.05 | 0.71 | (0.67) | 2.25 | |
| RXDX | Prometheus Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMGN | ImmunoGen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OSH | Oak Street Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intra Cellular Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intra Cellular stock to make a market-neutral strategy. Peer analysis of Intra Cellular could also be used in its relative valuation, which is a method of valuing Intra Cellular by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intra Cellular Market Strength Events
Market strength indicators help investors to evaluate how Intra Cellular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intra Cellular shares will generate the highest return on investment. By undertsting and applying Intra Cellular stock market strength indicators, traders can identify Intra Cellular Therapies entry and exit signals to maximize returns.
Intra Cellular Risk Indicators
The analysis of Intra Cellular's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Intra Cellular's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting intra stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.53 | |||
| Standard Deviation | 4.59 | |||
| Variance | 21.05 | |||
| Downside Variance | 0.4143 | |||
| Semi Variance | (0.56) | |||
| Expected Short fall | (1.67) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Intra Cellular
The number of cover stories for Intra Cellular depends on current market conditions and Intra Cellular's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intra Cellular is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intra Cellular's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Intra Cellular Short Properties
Intra Cellular's future price predictability will typically decrease when Intra Cellular's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intra Cellular Therapies often depends not only on the future outlook of the potential Intra Cellular's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intra Cellular's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 103.1 M | |
| Cash And Short Term Investments | 1 B |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Intra Stock
If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |